EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
News image
News image
On Air
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageThursday, October 1, 1998 Published at 10:42 GMT 11:42 UK
News image
News image
Health
News image
Breast cancer vaccine on trial
News image
A simple injection could prolong life
News image
The Imperial Cancer Research Fund has announced the start of a large scale trial of a vaccine to treat breast cancer.


News imageNews image
The BBC's Pallab Ghosh: "Encouraging results"
The study will involve more than 900 women worldwide and aims to show if the disease can be controlled by a simple monthly injection.

It will initially involve women with the disease in its advanced stages.

Standard treatments

When a woman is diagnosed as having breast cancer, doctors will first surgically remove any lumps.

They must then destroy any remaining cells using chemotherapy, a powerful cocktail of anti-cancer drugs.

However, chemotherapy has unpleasant side-effects and can be ineffective.


News imageNews image
Dr David Miles explains how the vaccine works
Dr David Miles, a consultant at Guy's and St Thomas's hospital, London, is co-ordinating the trial of the new vaccine.

He said: "Advanced breast cancer can be difficult to treat. The main aim is often to control the disease while allowing the patient to live as normal a life as possible.


[ image: Results so far have been promising]
Results so far have been promising
"This treatment appears to have few side-effects, can be easily applied once a month by injection, and allows patients to live their lives with what we hope will be minimal discomfort."

But Dr Miles said that even if the trial proves a success, the vaccine is unlikely to replace chemotherapy.

It would be used alongside the current treatments.

Immune response

The vaccine is thought to work by using the body's immune system.

Normally the immune system does not recognise cancerous cells as a threat, and so they are left to grow unhindered.

The vaccine is thought to work by "marking" cancers.

Normal cells have a protective coating of sugars around their core. In breast cancer cells, much of the coating is missing.

This means that sugars closer to the core are exposed.

Cancer cells destroyed

The vaccine targets one of these sugars, known as STn.

Antibodies in the immune system can then home in on the cancer cells and destroy them.

Early studies have shown promising results.

Dr Miles said: "Data from the studies suggest that the vaccine could help keep the disease at bay and prolong patients' lives.

"But the only way to be sure is by doing a much bigger study."

He said it would take four to five years before researchers knew the real value of the vaccine.

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
28 Sep 98�|�Health
Ginger Spice: 'I feared mastectomy'
News image
23 Sep 98�|�Medical notes
Breast cancer factfile
News image
17 Sep 98�|�Health
Chemotherapy that beats breast cancer
News image
07 Aug 98�|�Health
Tamoxifen could be first cancer prevention treatment
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
Imperial Cancer Research Fund
News image
Breakthrough Breast Cancer
News image
Guy's and St Thomas' Hospital Trust
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image